Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease | Nature Genetics | 2011 | 1.4K |
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial | Journal of the American College of Cardiology | 2014 | 972 |
n-3 fatty acids and serum lipoproteins: human studies | American Journal of Clinical Nutrition | 1997 | 850 |
The Omega-3 Index: a new risk factor for death from coronary heart disease? | Preventive Medicine | 2004 | 762 |
Obesity and the built environment | Journal of the American Dietetic Association | 2005 | 710 |
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis | Lancet, The | 2016 | 697 |
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry | Circulation | 2006 | 683 |
Excess Mortality among Persons with Type 2 Diabetes | New England Journal of Medicine | 2015 | 562 |
Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? | Journal of the American College of Cardiology | 2008 | 542 |
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention | JAMA - Journal of the American Medical Association | 2016 | 521 |
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors) | Circulation | 2017 | 519 |
Glycemic control and excess mortality in type 1 diabetes | New England Journal of Medicine | 2014 | 513 |
Rapid Response Teams: A Systematic Review and Meta-analysis | Archives of Internal Medicine | 2010 | 504 |
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association | Diabetes Care | 2009 | 500 |
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction | Nature | 2015 | 463 |
Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project) | Lancet, The | 2017 | 460 |
Stress-related cardiomyopathy syndromes | Circulation | 2008 | 424 |
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial | Circulation | 2015 | 410 |
5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials | Journal of the American College of Cardiology | 2017 | 407 |
A percutaneous treatment algorithm for crossing coronary chronic total occlusions | JACC: Cardiovascular Interventions | 2012 | 385 |
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making | Journal of the American College of Cardiology | 2013 | 373 |
Health status predicts long-term outcome in outpatients with coronary disease | Circulation | 2002 | 367 |
Monitoring clinical changes in patients with heart failure: a comparison of methods | American Heart Journal | 2005 | 366 |
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis | New England Journal of Medicine | 2017 | 363 |
Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT | Journal of Nuclear Cardiology | 2006 | 362 |